77 related articles for article (PubMed ID: 412076)
41. Circulating humoral antibodies in cancer.
Lewis MG
Med Clin North Am; 1972 Mar; 56(2):481-99. PubMed ID: 4556800
[No Abstract] [Full Text] [Related]
42. [ANTINUCLEAR ANTIBODIES AND DISEASES OF THE LYMPHORETICULAR SYSTEM].
MEYERZUM BUESCHENFELDE
Verh Dtsch Ges Inn Med; 1964; 70():235-9. PubMed ID: 14302406
[No Abstract] [Full Text] [Related]
43. Effect of toxin-antibody conjugates on tumor cells.
Uhr JW
Cell Immunol; 1982 Jan; 66(1):24-8. PubMed ID: 7044565
[No Abstract] [Full Text] [Related]
44. In-vivo cross reactions in the localization of anti-rat tumor antibodies. The localization in other tumors of antibodies prepared against a particular tumor.
PRESSMAN D; DAY ED
Acta Unio Int Contra Cancrum; 1959; 15():971-5. PubMed ID: 14434774
[No Abstract] [Full Text] [Related]
45. Initiation of immune responses against cancer cells.
Metcalf D
CA Cancer J Clin; 1972; 22(5):308-10. PubMed ID: 4627409
[No Abstract] [Full Text] [Related]
46. Antibodies in malignant disease.
Ablin RJ
Br Med J; 1972 Jun; 2(5816):767. PubMed ID: 4556545
[No Abstract] [Full Text] [Related]
47. [Self-defense reactions in neoplastic processes].
MATTEI A
Arch Hosp (Paris); 1949 Oct; 21(10):298-301. PubMed ID: 18148889
[No Abstract] [Full Text] [Related]
48. Circulating IgE levels in patients with gynecological tumors.
Tatra G; Lasnik E
Klin Wochenschr; 1985 Aug; 63(15):699-701. PubMed ID: 4046497
[TBL] [Abstract][Full Text] [Related]
49. [The influence of humoral immune mechanisms on metastasizing tumors in humans (author's transl)].
Lewis MG; Phillips TM; Rowden G; Hammer C
MMW Munch Med Wochenschr; 1977 Oct; 119(43):1393-6. PubMed ID: 412076
[TBL] [Abstract][Full Text] [Related]
50. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
51. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
52. Immunodeficiency and cancer: mechanisms involved.
Cottier H; Hess MW; Wälti ER
Schweiz Med Wochenschr; 1986 Aug; 116(34):1119-26. PubMed ID: 3532311
[TBL] [Abstract][Full Text] [Related]
53. Recurrent and metastatic malignant disease: immunological considerations.
Carter RL
Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
[No Abstract] [Full Text] [Related]
54. Appraisal of anti-idiotypic antibodies in the treatment of solid tumors in humans.
Euhus DM; Wong JH
Surg Gynecol Obstet; 1992 Jul; 175(1):89-96. PubMed ID: 1621207
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
